Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Oct;85(8):1162–1167. doi: 10.1054/bjoc.2001.2059

Identification and characterization of a novel human hepatocellular carcinoma-associated gene

Z-X Wang 1, H-Y Wang 2, M-C Wu 2
PMCID: PMC2375167  PMID: 11710830

Abstract

To investigate liver cancer-associated genes and to explore the molecular basis of liver cancer genesis, we have cloned a novel hepatocellular carcinoma (HCC)-related gene with a transcript of 2520 base pairs in length named HCCA2 by mRNA differential display polymerase chain reaction (DDPCR) and screening a placenta cDNA library. No significant homologous protein with known genes was found. Western blot analysis showed that HCCA2 could be expressed in transfected 293 cells. Northern hybridization analysis showed that HCCA2 mRNA was expressed in 79% (34/43) patients with HCC, most of whom had significantly high expression in HCC tissues, while not expressed in corresponding noncancerous liver tissues. The clinical pathological data showed that the HCCA2 was significantly associated with the invasion of tumour capsule (P= 0.0007) and the expression of ki-67 protein (P= 0.0022). Immunohistochemical staining confirmed that the HCCA2 protein was localized in cytoplasm of liver cancer tissues. According to amino acid analysis of the protein and its localization, it may play a role in a cascade of intracellular signal transduction because the protein was characterized with two Src homology 3 (SH3) binding-domains and several functional motifs of phophorylation. © 2001 Cancer Research Campaign  http://www.bjcancer.com

Keywords: hepatocellular carcinoma, differential display, gene clone, expression

Full Text

The Full Text of this article is available as a PDF (80.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  2. Cohen G. B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell. 1995 Jan 27;80(2):237–248. doi: 10.1016/0092-8674(95)90406-9. [DOI] [PubMed] [Google Scholar]
  3. Duvoux C. Epidémiologie et diagnostic des carcinomes hépatocellulaires sur cirrhose. Ann Chir. 1998;52(6):511–517. [PubMed] [Google Scholar]
  4. Fuchs M., Wang H., Ciossek T., Chen Z., Ullrich A. Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development. Mech Dev. 1998 Jan;70(1-2):91–109. doi: 10.1016/s0925-4773(97)00179-2. [DOI] [PubMed] [Google Scholar]
  5. Fujimoto Y., Hampton L. L., Wirth P. J., Wang N. J., Xie J. P., Thorgeirsson S. S. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 1994 Jan 1;54(1):281–285. [PubMed] [Google Scholar]
  6. Graves J. D., Krebs E. G. Protein phosphorylation and signal transduction. Pharmacol Ther. 1999 May-Jun;82(2-3):111–121. doi: 10.1016/s0163-7258(98)00056-4. [DOI] [PubMed] [Google Scholar]
  7. Hui A. M., Makuuchi M. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. Scand J Gastroenterol. 1999 Aug;34(8):737–742. doi: 10.1080/003655299750025642. [DOI] [PubMed] [Google Scholar]
  8. Johnson R. C. Hepatocellular carcinoma. Hepatogastroenterology. 1997 Jan-Feb;44(13):307–312. [PubMed] [Google Scholar]
  9. Kaita K. D., Pettigrew N., Minuk G. Y. Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue. Liver. 1997 Feb;17(1):13–16. doi: 10.1111/j.1600-0676.1997.tb00772.x. [DOI] [PubMed] [Google Scholar]
  10. Kang H., Freund C., Duke-Cohan J. S., Musacchio A., Wagner G., Rudd C. E. SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55. EMBO J. 2000 Jun 15;19(12):2889–2899. doi: 10.1093/emboj/19.12.2889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kondoh N., Wakatsuki T., Ryo A., Hada A., Aihara T., Horiuchi S., Goseki N., Matsubara O., Takenaka K., Shichita M. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res. 1999 Oct 1;59(19):4990–4996. [PubMed] [Google Scholar]
  12. Kozak M. The scanning model for translation: an update. J Cell Biol. 1989 Feb;108(2):229–241. doi: 10.1083/jcb.108.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liang P., Averboukh L., Pardee A. B. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res. 1993 Jul 11;21(14):3269–3275. doi: 10.1093/nar/21.14.3269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Liang P., Pardee A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992 Aug 14;257(5072):967–971. doi: 10.1126/science.1354393. [DOI] [PubMed] [Google Scholar]
  15. Loda M., Cukor B., Tam S. W., Lavin P., Fiorentino M., Draetta G. F., Jessup J. M., Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997 Feb;3(2):231–234. doi: 10.1038/nm0297-231. [DOI] [PubMed] [Google Scholar]
  16. Myllyharju J., Kivirikko K. I. Identification of a novel proline-rich peptide-binding domain in prolyl 4-hydroxylase. EMBO J. 1999 Jan 15;18(2):306–312. doi: 10.1093/emboj/18.2.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nagasaki K., Manabe T., Hanzawa H., Maass N., Tsukada T., Yamaguchi K. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett. 1999 Jun 1;140(1-2):227–234. doi: 10.1016/s0304-3835(99)00087-7. [DOI] [PubMed] [Google Scholar]
  18. Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis. 1999;19(3):235–242. doi: 10.1055/s-2007-1007113. [DOI] [PubMed] [Google Scholar]
  19. Schlott T., Ahrens K., Ruschenburg I., Reimer S., Hartmann H., Droese M. Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia. Br J Cancer. 1999 Apr;80(1-2):73–78. doi: 10.1038/sj.bjc.6690324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sherman M. Hepatocellular carcinoma. Gastroenterologist. 1995 Mar;3(1):55–66. [PubMed] [Google Scholar]
  21. Tiniakos D. G., Brunt E. M. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study. Liver. 1999 Feb;19(1):58–68. doi: 10.1111/j.1478-3231.1999.tb00011.x. [DOI] [PubMed] [Google Scholar]
  22. Wallner I., Hartmann H., Ramadori G. Aktuelle Therapiestrategien für das hepatozelluläre Karzinom, Teil 1. Leber Magen Darm. 1994 Jul;24(4):150, 153-4. [PubMed] [Google Scholar]
  23. Wang H., Lian Z., Lerch M. M., Chen Z., Xie W., Ullrich A. Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. Oncogene. 1996 Jun 20;12(12):2555–2562. [PubMed] [Google Scholar]
  24. Xu G. W., Sun Z. T., Forrester K., Wang X. W., Coursen J., Harris C. C. Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. Hepatology. 1996 Nov;24(5):1264–1268. doi: 10.1002/hep.510240546. [DOI] [PubMed] [Google Scholar]
  25. Zhang H., Zhang R., Liang P. Differential screening of gene expression difference enriched by differential display. Nucleic Acids Res. 1996 Jun 15;24(12):2454–2455. doi: 10.1093/nar/24.12.2454. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES